Cyprotex plc Company Profile (LON:CRX)

About Cyprotex plc

Cyprotex plc logoCyprotex PLC (Cyprotex) is a United Kingdom-based holding company. The Company is engaged in providing in vitro and in silico ADMET and PK (Absorption, Distribution, Metabolism, Excretion, Toxicity and Pharmacokinetics) information to various industries including the pharmaceutical, biotechnology, cosmetic, personal care, agrochemical, chemical industries and academia. The Company's trading subsidiaries are Cyprotex Discovery Limited and Cyprotex US, LLC (formerly Apredica LLC. Cyprotex provides a range of ADME Tox contract research services, which includes ADME screening, Customized ADME assays, Genomic ADME, In silico pharmacokinetics modeling and In vitro toxicology. It also offers integrated drug discovery services in collaboration with Sygnature Discovery and physicochemical profiling services in collaboration with Sirius Analytical.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CRX
  • CUSIP:
Key Metrics:
  • Previous Close: $1.91
  • 50 Day Moving Average: $135.99
  • 200 Day Moving Average: $110.37
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $32.69B
  • Outstanding Shares: 22,468,000
Additional Links:

Analyst Ratings

Consensus Ratings for Cyprotex plc (LON:CRX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cyprotex plc (LON:CRX)
Show:
DateFirmActionRatingPrice TargetDetails
11/17/2015N+1 SingerReiterated RatingcorporateView Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Cyprotex plc (LON:CRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cyprotex plc (LON:CRX)
Current Year EPS Consensus Estimate: $6.40 EPS

Dividends

Dividend History for Cyprotex plc (LON:CRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cyprotex plc (LON:CRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Cyprotex plc (LON:CRX)
DateHeadline
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: For the six months ended June 30, 2016 : August 12, 2016 (LON:CRX)
www.capitalcube.com - August 12 at 10:00 AM
biz.yahoo.com logoHalf Year 2016 Cyprotex PLC Earnings Release - Before Market Open (LON:CRX)
biz.yahoo.com - August 2 at 9:15 AM
4-traders.com logoCyprotex : Launch New Endocrine Disruption Service (LON:CRX)
www.4-traders.com - July 7 at 4:27 PM
publicnow.com logoCyprotex Launch New Endocrine Disruption Service (LON:CRX)
www.publicnow.com - July 7 at 6:01 AM
stockhouse.com logoLaunch of New Endocrine Disruption Service (LON:CRX)
www.stockhouse.com - June 23 at 10:10 AM
publicnow.com logoLaunch of chemTarget for Predicting Biological Target Interaction directly from Chemical Structure (LON:CRX)
www.publicnow.com - June 23 at 6:39 AM
stockhouse.com logoLaunch of chemTarget (LON:CRX)
www.stockhouse.com - June 16 at 9:43 PM
4-traders.com logoCyprotex : Purchase New IntelliCyt iQue® Screener for Expansion of Cell-Based Services (LON:CRX)
www.4-traders.com - June 16 at 8:48 AM
publicnow.com logoCyprotex Purchase New IntelliCyt iQue® Screener for Expansion of Cell-Based Services (LON:CRX)
www.publicnow.com - June 16 at 5:49 AM
publicnow.com logoLaunch of New Enhanced Version of chemPK™ Workflow Solution for Predicting Human Pharmacokinetics Directly from Chemical Structure (LON:CRX)
www.publicnow.com - May 20 at 5:23 AM
4-traders.com logoCyprotex : Launch of GLP-Compliant Genotoxicity Services (LON:CRX)
www.4-traders.com - May 17 at 1:59 PM
publicnow.com logoLaunch of GLP-Compliant Genotoxicity Services (LON:CRX)
www.publicnow.com - May 17 at 5:02 AM
proactiveinvestors.co.uk logoRisers & Fallers: Patagonia Gold, ITM Power, Cardiff Property, Sound Energy, Venn Life Sciences, CloudTag (LON:CRX)
www.proactiveinvestors.co.uk - May 10 at 1:37 PM
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: For the six months ended December 31, 2015 (LON:CRX)
www.capitalcube.com - April 5 at 2:17 PM
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: 2015 By the Numbers (LON:CRX)
www.capitalcube.com - April 5 at 1:49 PM
uk.finance.yahoo.com logoForm 8.3 - Cyprotex Plc (LON:CRX)
uk.finance.yahoo.com - April 4 at 7:36 AM
trustnet.com logoLaunch of Advanced 3D Liver Model (LON:CRX)
www.trustnet.com - March 31 at 12:36 PM
4-traders.com logoCyprotex : Launch of New Chemical and Cosmetics Testing Guide (LON:CRX)
www.4-traders.com - March 31 at 12:36 PM
uk.finance.yahoo.com logoCyprotex unveils new 3D liver model (LON:CRX)
uk.finance.yahoo.com - March 31 at 12:27 PM
trustnet.com logoLaunch of New Chemical and Cosmetics Testing Guide (LON:CRX)
www.trustnet.com - March 9 at 11:44 AM
capitalcube.com logoCyprotex Plc – Value Analysis (LONDON:CRX) : December 7, 2015 (LON:CRX)
www.capitalcube.com - December 7 at 3:07 PM
noodls.com logoLaunch of New Solution to Predict Preclinical Toxicity (LON:CRX)
www.noodls.com - November 27 at 9:15 AM
uk.finance.yahoo.com logoCyprotex expects full year results to be ahead of expectations (LON:CRX)
uk.finance.yahoo.com - October 23 at 7:11 AM
noodls.com logoCyprotex PLC - Partnership in the EC funded EU-ToxRisk consortium (LON:CRX)
www.noodls.com - October 15 at 9:02 AM
noodls.com logoCyprotex launches new chemPKTM workflow solution to predict human pharmacokinetics directly from chemical structure (LON:CRX)
www.noodls.com - July 16 at 11:43 AM
uk.finance.yahoo.com logoCyprotex launches new Biosciences division (LON:CRX)
uk.finance.yahoo.com - July 16 at 5:06 AM
uk.finance.yahoo.com logoCyprotex posts operating loss for first time in 7 years after contract delays in the US (LON:CRX)
uk.finance.yahoo.com - April 15 at 12:51 PM
noodls.com logoCyprotex launches new high throughput laboratory in its US facility (LON:CRX)
www.noodls.com - April 1 at 8:44 AM
noodls.com logoCyprotex launch Short Time Exposure service for identifying potential serious eye damage for new chemicals (LON:CRX)
www.noodls.com - March 19 at 5:25 AM
noodls.com logoCyprotex appoints Dr Rob Elsby as Leader of Drug Transporter Team (LON:CRX)
www.noodls.com - March 12 at 5:39 AM

Social


Last Updated on 8/25/2016 by MarketBeat.com Staff